Pacific Biosciences

158 articles with Pacific Biosciences

• Discovery Life Sciences Becomes Global Center Of Excellence For PacBio Long-Read Genomic Sequencing

  10/15/2019

  Significant Investment to Accelerate Cancer Research Creates First Commercial Single Source for Combined FFPE Acquisition, FFPE RNA Isolation and Long-Read Sequencing

• Highly Accurate SMRT Sequencing for Human Genetics to Be Showcased at ASHG 2019 Annual Meeting

  10/10/2019

  Pacific Biosciences of California, Inc. announced that more than 50 presentations will include data from the company’s Single Molecule, Real-Time sequencing platforms at next week’s American Society for Human Genetics 2019 annual meeting in Houston.

• Phase Genomics’ Platform Links Viruses and Antibiotic Resistance Genes to the Microbiome in Study of a Highly Complex Microbial Community

  8/6/2019

  New Study of Cow Rumen Finds Hundreds of New Viral and Antibiotic Resistance Hosts in Complex Microbiome Sample by Leveraging Proprietary Proximity Ligation Platform

• 

  Top 10 Gene Sequencing Companies by Revenue

  4/18/2019

  The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.
• 

  Illumina Acquires Pacific Biosciences for $1.2 Billion

  11/2/2018

  The deal to acquire its rival, Pacific Biosciences, will provide Illumina with a more comprehensive sequencing test at a lower cost.

• Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery

  11/1/2018

  Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome

• Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock

  2/13/2018

  Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

• Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore

  2/9/2018

  The decision by the ITC is based on its interpretation that the term “single-molecule sequencing” is limited to sequencing-by-synthesis approaches, and that Oxford Nanopore’s sequencing approach is therefore not “single-molecule sequencing.”

• Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

  2/2/2018

  Product, service and other revenue for the year ended December 31, 2017 increased by 19% to $93.5 million, compared to $78.6 million for 2016.

• BGI Increases Long-Read Sequencing Capacity With Purchase of 10 PacBio Sequel Systems

  1/25/2018

  This will significantly expand the capacity for Single Molecule, Real-Time Sequencing for BGI’s global sequencing service business, which currently operates two Sequel Systems and a PacBio RS II Sequencing System.

• Pacific Biosciences of California Announces Third Quarter 2017 Financial Results

  11/3/2017

  Product, service and other revenue for the third quarter of 2017 increased by 9% to $23.5 million, compared to $21.5 million for the third quarter of 2016.

• Pacific Biosciences Appoints Kathy Ordonez as Chief Commercial Officer

  11/3/2017

  Ms. Ordonez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies.

• PacBio's Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes

  10/16/2017

  A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time Sequencing for discovering structural variants throughout the human genome

• Pacific Biosciences And Bluebee Launch De Novo Genome Assembly Pipeline On The Bluebee Analysis Platform

  10/9/2017

• Biophysics Study Makes Exciting Advancements For The Future Of DNA Sequencing, Pacific Biosciences Reveals

  9/12/2017

• Pacific Biosciences Announces Second Quarter 2017 Financial Results

  8/3/2017

• Pacific Biosciences Announces New Agreement With Novogene To Purchase Ten Sequel Systems

  8/3/2017

• Pacific Biosciences Second Quarter 2017 Financial Results Call

  7/25/2017

• Novogene And Pacific Biosciences To Jointly Develop And Co-Market Novel Applications Based On Sequel Platform

  7/18/2017

• Pacific Biosciences Technology Resolves Complex Maize Genome, Driving Demand For Other Large-Scale AgBio Sequencing Projects

  6/22/2017